DE69019795T2 - Verfahren zur Feststellung der Empfindlichkeit von HIV-1 für Zidovudine und dazu geeignete Oligonukleotide. - Google Patents

Verfahren zur Feststellung der Empfindlichkeit von HIV-1 für Zidovudine und dazu geeignete Oligonukleotide.

Info

Publication number
DE69019795T2
DE69019795T2 DE69019795T DE69019795T DE69019795T2 DE 69019795 T2 DE69019795 T2 DE 69019795T2 DE 69019795 T DE69019795 T DE 69019795T DE 69019795 T DE69019795 T DE 69019795T DE 69019795 T2 DE69019795 T2 DE 69019795T2
Authority
DE
Germany
Prior art keywords
zidovudine
hiv
sensitivity
determining
suitable oligonucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69019795T
Other languages
English (en)
Other versions
DE69019795D1 (de
Inventor
Brendan Alexander Larder
Sharon Dawn Symons
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10661415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69019795(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of DE69019795D1 publication Critical patent/DE69019795D1/de
Application granted granted Critical
Publication of DE69019795T2 publication Critical patent/DE69019795T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DE69019795T 1989-08-09 1990-08-08 Verfahren zur Feststellung der Empfindlichkeit von HIV-1 für Zidovudine und dazu geeignete Oligonukleotide. Expired - Lifetime DE69019795T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898918226A GB8918226D0 (en) 1989-08-09 1989-08-09 Dna assays

Publications (2)

Publication Number Publication Date
DE69019795D1 DE69019795D1 (de) 1995-07-06
DE69019795T2 true DE69019795T2 (de) 1995-11-02

Family

ID=10661415

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69019795T Expired - Lifetime DE69019795T2 (de) 1989-08-09 1990-08-08 Verfahren zur Feststellung der Empfindlichkeit von HIV-1 für Zidovudine und dazu geeignete Oligonukleotide.

Country Status (12)

Country Link
US (2) US5409810A (de)
EP (1) EP0422762B1 (de)
JP (1) JP3105907B2 (de)
AU (1) AU638475B2 (de)
CA (1) CA2022942C (de)
DE (1) DE69019795T2 (de)
DK (1) DK0422762T3 (de)
ES (1) ES2072983T3 (de)
GB (1) GB8918226D0 (de)
IE (1) IE69846B1 (de)
NZ (1) NZ234812A (de)
ZA (1) ZA906263B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39282E1 (en) * 1989-08-09 2006-09-12 Smithkline Beecham Corporation Nucleic acid derivatives
CA2042093C (en) * 1990-05-09 2002-12-24 Gyula Hadlaczky Cell line carrying an excess of mammalian centromeres
AU1741692A (en) * 1991-03-13 1992-10-21 Regents Of The University Of California, The Detection of 3'-azido-3'-deoxythymidine resistance
DE4129653A1 (de) * 1991-09-06 1993-03-11 Boehringer Mannheim Gmbh Verfahren zum nachweis aehnlicher nukleinsaeuren
WO1993023574A1 (en) * 1992-05-14 1993-11-25 Kozal Michael J Polymerase chain reaction assays for monitoring antiviral therapy
US5827648A (en) * 1995-12-13 1998-10-27 Chiron Corporation Differential hybridization for relative quantification of variant populations
DE69507022T2 (de) * 1994-04-19 1999-06-24 Sanquin Bloedvoorziening Verfahren zur unterscheidung zwischen den varianten des menschlichen immunschwächevirus, die syncytien induzieren, und denen, die keine syncytien induzieren und primers zur verwendung in den verfahren
US6265152B1 (en) 1995-12-22 2001-07-24 Visible Genetics Inc. Method and kit for evaluation of HIV mutations
US6007983A (en) * 1995-12-22 1999-12-28 Visible Genetics Inc. Method and kit for evaluation of HIV mutations
EP0817866A1 (de) 1996-01-26 1998-01-14 Innogenetics N.V. Verfahren für den nachweis von drogen-induzierten mutationen in dem reverse transcriptase gen
US6077697A (en) * 1996-04-10 2000-06-20 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US20030033617A1 (en) * 1996-04-10 2003-02-13 Gyula Hadlaczky Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6025155A (en) * 1996-04-10 2000-02-15 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US20020160970A1 (en) * 1996-04-10 2002-10-31 Gyula Hadlaczky Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6830887B2 (en) 1997-03-18 2004-12-14 Bayer Healthcare Llc Method and kit for quantitation and nucleic acid sequencing of nucleic acid analytes in a sample
AU4716299A (en) 1998-06-24 2000-01-10 Emory University Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv
US7115584B2 (en) * 1999-01-22 2006-10-03 Emory University HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
US7635690B2 (en) 1999-01-22 2009-12-22 Emory University HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
US6300075B1 (en) * 1999-02-03 2001-10-09 Ortho-Clinical Diagnostics, Inc Enhancement of the specificity of nucleic acid amplification by carrier nucleic acid
US7074556B2 (en) * 1999-03-02 2006-07-11 Invitrogen Corporation cDNA synthesis improvements
NZ516259A (en) 1999-05-28 2004-02-27 Virco N New mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance
EP1315839B9 (de) * 2000-09-01 2009-08-12 Gen-Probe Incorporated Amplifizierung von hiv-1 sequenzen zur detektion von sequenzen, die mit wirkstoff-resistenz mutationen einhergehen
AU2002218447C9 (en) * 2000-09-28 2008-04-17 Bioriginal Food & Science Corporation Fad4, Fad5, Fad5-2, and Fad6, fatty acid desaturase family members and uses thereof
AU2002226316B2 (en) 2000-10-20 2008-06-26 Virco Bvba Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance
AU2003254500B2 (en) 2002-07-01 2009-11-19 Tibotec Pharmaceuticals Ltd. Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance
EP1522039B1 (de) 2002-07-01 2008-06-04 Tibotec Pharmaceuticals Ltd. Mit phänotypischer medikamentenresistenz korrelierte mutationsprofile in hiv-1-reverse-transkriptase
US6834479B2 (en) * 2002-10-03 2004-12-28 Src Innovations, Llc Bagging machine having a collapsible tunnel
KR101591986B1 (ko) * 2014-02-26 2016-02-05 연세대학교 산학협력단 압축 공기로 펼쳐지는 확공 날개를 구비한 굴착 비트
KR101796939B1 (ko) * 2016-02-19 2017-11-13 박민서 공압식 굴착 머신 및 이를 이용한 굴착공 굴착 공법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU606043B2 (en) * 1985-03-28 1991-01-31 F. Hoffmann-La Roche Ag Detection of viruses by amplification and hybridization

Also Published As

Publication number Publication date
JPH03133400A (ja) 1991-06-06
IE69846B1 (en) 1996-10-02
AU6082890A (en) 1991-02-14
EP0422762A2 (de) 1991-04-17
NZ234812A (en) 1991-09-25
ZA906263B (en) 1992-04-29
EP0422762A3 (en) 1992-08-05
GB8918226D0 (en) 1989-09-20
DE69019795D1 (de) 1995-07-06
AU638475B2 (en) 1993-07-01
US5409810A (en) 1995-04-25
EP0422762B1 (de) 1995-05-31
JP3105907B2 (ja) 2000-11-06
DK0422762T3 (da) 1995-07-24
ES2072983T3 (es) 1995-08-01
IE902860A1 (en) 1991-02-27
USRE37918E1 (en) 2002-12-03
CA2022942A1 (en) 1991-02-10
CA2022942C (en) 1999-12-21

Similar Documents

Publication Publication Date Title
DE69019795D1 (de) Verfahren zur Feststellung der Empfindlichkeit von HIV-1 für Zidovudine und dazu geeignete Oligonukleotide.
DE3854546D1 (de) Verfahren und Gerät zur Programmablaufmessung.
DE3854334T2 (de) Verfahren und Gerät zur Bestimmung von Substanzen.
DE3689619T2 (de) Verfahren und vorrichtung zur bestimmung der konzentration von asphalten.
DE68907407D1 (de) Verfahren zur sequenzanalyse von dna.
DE69022786T2 (de) Verfahren zur Bestimmung der Konzentration von Glucose.
DE3673527D1 (de) Verfahren und vorrichtung zur bestimmung von parametern gasfoermiger substanzen.
DE69010143T2 (de) Testeinrichtung und Verfahren zur Bestimmung von Fructoasminen.
LU80213A1 (de) Verfahren und reagens zur bestimmung von alpha-amylase
DE3863895D1 (de) Verfahren und vorrichtung zur erzielung von seismischen messwerten.
DE69120359D1 (de) Verfahren zur identifizierung von candida albicans mittels chromogener substanzen
DE69032422T2 (de) Reagenzzusammensetzung, Verfahren und Kits zur Quantifizierung von Magnesium oder Calcium und Magnesium
DE3863285D1 (de) Verfahren und reagenz zur bestimmung von persaeuren.
DE68919256T2 (de) Verfahren und Vorrichtung zur Ermittlung von Zelleigenschaften.
DE3669591D1 (de) Verfahren und vorrichtung zur ermittlung der adhaesion von zellen.
DE3776395D1 (de) Analytisches element und verfahren zur bestimmung von magnesium-ionen.
AT360661B (de) Verfahren zur bestimmung von prothrombin und reagens zur durchfuehrung des verfahrens
DE3783773T2 (de) Vorrichtung zur feststellung der lebensfaehigkeit von nematoden und verfahren zu ihrer verwendung.
DE3764295D1 (de) Verfahren und vorrichtung zur pruefung von faeden.
DE69026611D1 (de) Verfahren zur Bestimmung von Fruktosaminen
DE68916773D1 (de) Verfahren und Anordnung zur Detektion von Übermodulation für die Signalanalyse.
ATE263T1 (de) Verfahren und reagenz zur bestimmung der creatinkinase-mb.
ATA3685A (de) Verfahren zur bestimmung des bruchverhaltens von probekoerpern
DE69005469D1 (de) Verfahren und Apparatur zur Messung von kleinen Kapazitäten.
ATA397584A (de) Vorrichtung zur korrosionspruefung von pruefkoerpern

Legal Events

Date Code Title Description
8363 Opposition against the patent